Overview

Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease.

Status:
Terminated
Trial end date:
2018-01-16
Target enrollment:
Participant gender:
Summary
Phase 3, international, multicenter, open-label 12 month safety study.
Phase:
Phase 3
Details
Lead Sponsor:
Biotie Therapies Inc.
Collaborator:
Acorda Therapeutics
Treatments:
Levodopa